STOCK MARKET BSE NSE

Govt allocates additional vials of Amphotericin-B to states, union territories for black fungus treatment

The allocation of the drug is being made to ensure its smooth supply and timely treatment of patients, Union Minister Sadananda Gowda added.

Published: 14th June 2021 05:53 PM  |   Last Updated: 14th June 2021 05:53 PM   |  A+A-

Doctors treat a patient infected with black fungus.

Doctors treat a patient infected with black fungus. (File Photo | PTI)

By PTI

NEW DELHI: The government on Monday allocated an additional 1,06,300 vials of Liposomal Amphotericin-B, used to treat black fungus infection, to states, Union Territories (UTs) and central institutions, Union Minister Sadananda Gowda said.

Amphotericin-B is used to treat Mucormycosis, also known as black fungus, which damages the nose, eyes, sinuses, and sometimes even the brain.

"Ensuring significant availability of Liposomal #Amphotericin B, additional 1,06,300 vials of the drug have been allocated across all the states/UTs and Central institutions today," the minister of chemicals and fertilisers tweeted.

He added that another 53,000 vials of conventional Amphotericin-B have been given to states and UTs.

"A total of 53,000 vials of Conventional #Amphotericin B have also been allocated to all the States/UTs & Central Institutions today," Gowda said.

The allocation of the drug is being made to ensure its smooth supply and timely treatment of patients, he added.

Liposomal formulations are less expensive and have less renal toxicity than simple Amphotericin B.

Mucormycosis is a very rare infection which is caused by exposure to mucor mould which is commonly found in soil, plants, manure, and decaying fruits and vegetables.

It affects the sinuses, the brain and the lungs and can be life-threatening in diabetic or severely immuno-compromised individuals such as cancer patients or people with HIV/AIDS.

There have been an alarming number of cases of Mucormycosis among patients with COVID-19 and those who have recently recovered.

Doctors believe that Mucormycosis may be triggered by the use of steroids, a life-saving treatment for severe and critically ill COVID-19 patients.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp